Osteopontin function in pathology: Lessons from osteopontin-deficient mice

Experimental Nephrology

Volumn 7, Issue 2, 1999, Pages 103-113

  Denhardt, David T ^a   Rittling, Susan R ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Injury; Knockout mice; Macrophages; Osteopontin

Indexed keywords

OSTEOPONTIN; PHOSPHOPROTEIN;

KIDNEY DISEASE; KNOCKOUT MOUSE; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; MAMMAL; MOUSE; NONHUMAN; OSTEOCLAST; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL ADHESION; HUMANS; INTEGRINS; KIDNEY; KIDNEY NEOPLASMS; MAMMALS; MICE; MICE, KNOCKOUT; OSTEOPONTIN; PHOSPHOPROTEINS; SIALOGLYCOPROTEINS;

EID: 0345188617     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Denhardt DT, Guo X: Osteopontin: A protein with diverse functions. FASEB J 1993;7:1475-1482.
2. Patarca R, Saavedra RA, Cantor H: Molecular and cellular basis of genetic resistance to bacterial infection: The role of the early T-lymphocyte activation 1/osteopontin gene. Crit Rev Immunol 1993;13:225-246.
3. Weber GF, Cantor H: The immunology of Eta-1/osteopontin. Cytokine Growth Factor Rev 1996;7:241-246.
4. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM: Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993;92:1686-1696.
5. 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circ Res 1995;77:665-672.
6. Prince CW, Oosawa T, Butler WT, Tomana M, Bhown AS, Bhown M, Schrohenloher RE: Isolation, characterization and biosynthesis of a phosphorylated glycoprotein from rat bone. J Biol Chem 1987;262:2900-2907.
7. Sørensen ES, Hojrup P, Petersen TE: Post-translational modification of bovine osteopontin: Identification of twenty-eight phosphorylation and three O-glycosylation sites. Protein Sci 1995;4:2040-2049.
8. Butler WT, Ridall AL, McKee MD: Osteopontin: in Bilezikian JP, Raisz LG, Rodan GA (eds): Principles of Bone Biology. San Diego, Academic Press, 1996, pp 167-181.
9. 3 in smooth muscle migration to osteopontin in vitro. J Clin Invest 1995;95:713-724.
10. 3. J Biol Chem 1995;270:9917-9925.
11. 5. J Biol Chem 1995;270:26232-26238.
12. 1 integrin. J Biol Chem 1996;271:28485-28491.
13. 1 and potential roles for this integrin-ligand interaction in kidney morphogenesis. Mol Biol Cell 1998;9:1425-1435.
14. 1 integrin. J Cell Sci 1998;111:1165-1174.
15. Weber GF, Ashkar S, Glimcher MJ, Cantor H: Receptor-ligand interaction between CD44 and osteopontin (ETA-1). Science 1996;271:509-512.
16. Singh RP, Patarca R, Schwartz J, Singh P, Cantor H: Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med 1990;171:1931-1942.
17. 3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci USA 1997;94:9308-9313.
18. Somerman MJ, Prince CW, Sauk JJ, Foster RA, Butler WT: Cell attachment activity of the 44 kilodalton bone phosphoprotein is not restricted to bone cells. Matrix 1987;9:49-54.
19. Chambers AF, Hota C, Prince CW: Adhesion of metastatic, ras-transformed NIH 3T3 cells to osteopontin, fibronectin, and laminin. Cancer Res 1993;53:701-706.
20. Senger DR, Perruzzi CA, Papadopoulous-Sergiou A, Van De Water L: Adhesive properties of osteopontin: Regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell 1994;5:565-574.
21. Katagiri YU, Murakami M, Mori K, Iizuka J, Hara T, Tanaka K, Jia WY, Chambers AF, Uede T: Non-RGD domains of osteopontin promote cell adhesion without involving alpha v integrins. J Cell Biochem 1996;62:123-131.
22. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM: Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994;74:214-224.
23. Senger DR, Perruzzi CA: Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin. Biochim Biophys Acta 1996;1314:13-24.
24. Hwang SM, Lopez CA, Heck DE, Gardner CR, Laskin DL, Laskin JD, Denhardt DT: Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 1994;269:711-715.
25. Rollo EE, Laskin DL, Denhardt DT: Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW 264.7 macrophages. J Leukoc Biol 1996;60:397-404.
26. Lampe MA, Patarca R, Iregui MV, Cantor H: Polyclonal B-cell activation by the Eta-1 cytokine and the development of autoimmune disease. J Immunol 1991;147:2902-2906.
27. Bosky AL, Maresca M, Ullrich W, Doty SB, Butler WT, Prince CW: Osteopontin-hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite formation and growth in a gelatin gel. Bone Miner 1993;22:147-159.
28. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA: Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 1996;317:59-64.
29. Shiraga H, Min W, Van Dusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Neilson EG, Hoyer JR: Inhibition of calcium oxalate crystal growth in vitro by uropontin, a new member of the aspartic-acid rich protein superfamily. Proc Natl Acad Sci USA 1992;89:426-430.
30. Worcester EM, Blumenthal SS, Beshensky AM, Lewand DL: The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res 1992;7:1029-1036.
31. 3 integrin-induced endothelial cell survival. J Cell Biol 1998;141:1083-1093.
32. Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT: Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 1998;13:1101-1111.
33. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BLM: Altered wound healing in mice lacking a functional osteopontin gene (sppl). J Clin Invest 1998;101:1468-1478.
34. Rodan GA: Osteopontin overview. Ann NY Acad Sci 1995;760:1-5.
35. Nomura S, Wills AJ, Edwards DR, Heath JK, Hogan BLM: Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol 1988;106:441-450.
36. Stern DN, Glimcher MJ, Saavedra RA: Localization of osteopontin during mouse development. Ann NY Acad Sci 1995;760:367-370.
37. Rogers SA, Padanilam BJ, Hruska KA, Giachelli CM, Hammerman MR: Metanephric osteopontin regulates nephrogenesis in vitro. Am J Physiol 1997;272:F469-F476.
38. Rittling SR, Novick KW: Osteopontin expression in mammary gland development and tumorigenesis. Cell Growth Differ 1997;8:1061-1069.
39. Rittling SR, Feng F: Detection of mouse osteopontin by Western blotting. Biochem Biophys Res Commun 1998;250:287-292.
40. Wesson JA, Worcester EM, Weissner JH, Mandel NS, Kleinman JG: Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules. Kidney Int 1998;53:952-957.
41. Kleinman JG, Beshensky AM, Worcester EM, Brown D: Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int 1995;47:1585-1596.
42. Lopez CA, Hoyer JR, Wilson PD, Waterhouse P, Denhardt DT: Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli. Lab Invest 1993;69:355-363.
43. Giachelli CM, Pichler R, Lombardi D, Denhardt DT, Alpers CE, Schwartz SM, Johnson RJ: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 1994;45:515-524.
44. Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, Johnson RJ: Tubulointerstitial disease in glomerulonephritis: Potential role of osteopontin. Am J Pathol 1994;144:915-926.
45. Pichler R, Franceschini N, Young BA, Hugo C, Andoh TF, Burdmann EA, Shankland SJ, Alpers CE, Bennett WM, Couser WG: Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 1995;6:1186-1196.
46. Eddy AA, Giachelli CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 1995;47:1546-1557.
47. Diamond JR, Kees-Folts D, Ricardo SD, Eufemio M: Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am J Physiol 1995;146:1455-1466.
48. Lan HY, Yu XQ, Yang N, Nikolic-Paterson DJ, Mu W, Pichler R, Johnson RJ, Atkins RC: De novo glomerular osteopontin expression in rat crescentic glomerulonephritis. Kidney Int 1998;53:136-145.
49. Nambi P, Gellai M, Wu HL, Prabhakar U: Upregulation of osteopontin in ischemia-induced renal failure in rats: A role for ET-I? Biochem Biophys Res Commun 1997;241:212-214.
50. Noiri E, Peresleni T, Miller F, Goligorsky MS: In vivo targeting of inducible iNOS synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 1996;97:2377-2383.
51. Noiri E, Dickman K, Miller F, Romanov G, Romanov V, Shaw R, Rittling SR, Denhardt DT, Goligorsky MS: Acute renal ischemia in mice with a targeted disruption of the osteopontin gene: Link to nitric oxide-induced injury. Kidney Int, in press.
52. Ophascharoensuk V, Giachelli CM, Liaw L, Shankland SJ, Couser WG, Johnson RJ: Osteopontin (OPN) mediates early macrophage influx in renal interstitial inflammation: A study in OPN knockout (KO) mice (abstract). J Am Soc Nephrol 1997;8:481.
53. Yu XQ, Nikolic-Paterson DJ, Mu W, Giachelli CM, Atkins RC, Johnson RJ, Lan HY: A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat. Proc Assoc Am Physicians 1998;110:50-64.
54. Giachelli CM, Schwartz SM, Liaw L: Molecular and cellular biology of osteopontin. Trends Cardiovasc Med 1995;5:88-95.
55. Wang X, Louden C, Yue TL, Ellison JA, Barone FC, Solleveld HA, Feuerstein GZ: Delayed expression of osteopontin after focal stroke in the rat. J Neurosci 1998;18:2075-2083.
56. Williams EB, Halpert I, Wickline S, Davison G, Parks WC, Rottman JN: Osteopontin expression is increased in the heritable cardiomyopathy of Syrian hamsters. Circulation 1995;92:705-709.
57. Senger DR, Asch BB, Smith BD, Perruzzi CA, Dvorak HF: A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells. Nature 1983;302:714-715.
58. Brown LF, Papadopoulous-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF, Senger DR: Osteopontin expression and distribution in human carcinomas. Am J Pathol 1994;145:610-623.
59. Bellahcène A, Castronovo V: Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol 1995;146:95-100.
60. Senger DR, Perruzzi CA, Papadopoulous A: Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res 1989;9:1291-1300.
61. Chambers AF, Behrend EI, Wilson SM, Denhardt DT: Induction of expression of osteopontin (OPN, secreted phosphoprotein) in metastatic, ras-transformed NIH-3T3 cells. Anticancer Res 1992;12:43-48.
62. Guo X, Zhang YP, Mitchell DA, Denhardt DT, Chambers AF: Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell. Mol Cell Biol 1995;15:476-487.
63. Denhardt DT, Chambers AF: Overcoming obstacles to metastasis - a defense against host defenses: Osteopontin (OPN) as a shield against attack by cytotoxic host cells. J Cell Biochem 1994;56:48-51.
64. Montgomery AM, Reisfeld RA, Cheresh DA: Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci USA 1994;91:8856-8860.
65. Behrend EI, Craig AM, Wilson SM, Denhardt DT, Chambers AF: Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res 1994;54:832-837.
66. Gardner HAR, Berse B, Senger DR: Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts. Oncogene 1994;9:2321-2326.
67. Su L, Mukherjee AB, Mukherjee BB: Expression of antisense osteopontin mRNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells. Oncogene 1995;10:2163-2169.
68. Wu YM, Denhardt DT, Rittling SR: Attenuation of the transformation phenotype in the absence of osteopontin, in preparation.
69. Miyazaki Y, Setoguchi S, Yoshida S, Higuchi Y, Akizuki S, Yamamoto S: The mouse osteopontin gene: Expression in monocytic lineages and complete nucleotide sequence. J Biol Chem 1990;265:14432-14438.
70. Rollo EE, Denhardt DT: Differential effects of osteopontin on the cytotoxic activity of macrophages from young and old mice. Immunology 1996;88:642-647.
71. Krause SW, Rehli M, Kreutz M, Schwarzfischer L, Paulauskis JD, Andreesen R: Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol 1996;60:540-545.
72. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M: Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 1998;152:353-358.
73. Tian JY, Sørensen ES, Butler WT, Lopez CA, Sy MS, Denhardt DT: Regulation of NO synthesis induced by inflammatory mediators in RAW 264.7 cells: collagen blocks inhibition by osteopontin, submitted.
74. Yoshitake H, Rittling SR, Denhardt DT, Noda M: Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption, submitted.
75. Väänänen K: Osteoclast function: Biology and mechanism; in Bilezikian JP, Raisz LG, Rodan GA (eds): Principles of Bone Biology. San Diego, Academic Press, 1996, pp 103-114.
76. Flores M, Norgard M, Heinegård D, Reinholt FP, Andersson G: RGD-directed attachment of rat osteoclasts to osteopontin, bone sialoprotein and fibronectin. Exp Cell Res 1992;201:526-530.
77. 3 potentiate bone resorption. J Biol Chem 1993;268:9901-9907.
78. 3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem 1991;266:20369-20374.
79. Matsumoto HN, Tamura M, Denhardt DT, Obinata M, Noda M: Establishment and characterization of bone marrow stromal cell lines that support osteoclastogenesis. Endocrinology 1995;136:4084-4091.
80. Chackalaparampil I, Peri A, Nemir M, McKee MD, Lin PH, Mukherjee BB, Mukherjee AB: Cells in vivo and in vitro from osteopetrotic mice homozygous for c-src disruption show suppression of synthesis of osteopontin, a multifunctional extracellular matrix protein. Oncogene 1996;12:1457-1467.
81. Rollo EE, Hempson SJ, Rittling SR, Denhardt DT, Mackow ER, Shaw RD: The extracellular matrix protein osteopontin is an element of the host mucosal defense against rotavirus diarrhea, in preparation.
82. Juliano RL, Haskill S: Signal transduction from the extracellular matrix. J Cell Biol 1993;120:577-585.
83. Zheng X, Saunders TL, Camper SA, Samuelson LC, Ginsburg D: Vitronectin is not essential for normal mammalian development and fertility. Proc Natl Acad Sci USA 1995;92:12426-12430.
84. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S: Mice develop normally without tenascin. Genes Dev 1992;6:1821-1831.
85. Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO: Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 1998;101:982-992.
86. Gilmour DT, Lyon GJ, Carlton MB, Sanes JR, Cunningham JM, Anderson JR, Hogan BL, Evans MJ, Colledge WH: Mice deficient for the secreted glycoprotein SPARC/osteonectin/ BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J 1998;17:1860-1870.
87. Murry CE, Giachelli CM, Schwartz SM, Vracko R: Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 1994;145:1450-1462.
88. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM: Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 1994;14:1648-1656.
89. Carlson I, Tognazzi K, Manseau EJ, Dvorak HF, Brown LF: Osteopontin is strongly expressed by histiocytes in granulomas of diverse etiology. Lab Invest 1997;77:103-108.
90. Nau GJ, Guilfoile P, Chupp GL, Berman JS, Kim SJ, Kornfield H, Young RA: A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc Natl Acad Sci USA 1997;94:6414-6419.
91. McKee MD, Nanci A: Secretion of osteopontin by macrophages and its accumulation at tissue surfaces during wound healing in mineralized tissues: A potential requirement for macrophage adhesion and phagocytosis. Anat Rec 1996;245:394-409.